Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications

OBJECTIVE: The aim of this study was to provide a systematic safety analysis of gadobutrol after more than 29 million applications in clinical routine. MATERIALS AND METHODS: Forty-two clinical development phase II to IV studies on gadobutrol or comparator and the postmarketing safety surveillance d...

Descripción completa

Detalles Bibliográficos
Autores principales: Endrikat, Jan, Vogtlaender, Kai, Dohanish, Susan, Balzer, Thomas, Breuer, Josy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982758/
https://www.ncbi.nlm.nih.gov/pubmed/26964075
http://dx.doi.org/10.1097/RLI.0000000000000270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982758/
https://www.ncbi.nlm.nih.gov/pubmed/26964075
http://dx.doi.org/10.1097/RLI.0000000000000270

Ejemplares similares